Imcyse

Avenue du Pré-Aily 14

4031 Liège Angleur

BE

Imcyse

Foundation date

10/08/2010

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Imcyse develops active targeted immune therapies (ImotopesÔ) that locally inhibit the immune cells involved in the destruction of the diseased organ. The targeted approach and memory effect of the Imcyse technology help to prevent and cure diseases with no current therapeutic alternative, caused by disruptions of the immune system without impairing the patient’s immune defences. 

Upcoming events

Latest news

  • Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

    7 hours ago

  • Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology

    1 day ago

  • Fat creates an ideal environment for metastatic breast tumors

    1 day ago